LMND raises full-year 2026 revenue guidance while reaffirming adjusted EBITDA profitability by Q4 2026 and 33% in-force premium growth. Lemonade raised its 2026 revenue guidance and maintained its target for positive adjusted EBITDA by Q4 2026. The insurtech firm also proj
Bank reports Q2 2026 net income of $57.7 million and $0.25 per share as tangible book value rises to $7.56. Mechanics Bancorp announced a $250 million dividend plan through 2027 and targets a $430 million run-rate for noninterest expenses by Q4 2026. The bank posted Q2 202
Allogene Therapeutics secures dual FDA designations for its allogeneic CAR-T candidate, accelerating development and review pathways. Allogene Therapeutics (ALLO) shares climbed after the FDA designated its cell therapy candidate, cemacabtagene ansegedleucel (cema-cel), as
Vacation-home demand was expected to remain sluggish, as the broader housing market was marred by elevated mortgage rates and weaker transaction activity. However, according to new Redfin data, there's an unexpected shift in one corner of the housing market, breaking a tre
The HVAC manufacturer lowered full-year guidance after a 12% drop in residential unit volume and delayed demand recovery to 2027. Lennox International reduced its 2026 adjusted EPS forecast to $23-$24, down from prior expectations, citing a 12% decline in residential unit
Quick Read - PLTR trades at 147x trailing earnings, and insiders Karp and Sankar unloaded shares in a price range from $130 to $137 as recently as July 2026. - Since May earnings, PLTR has dropped 14% while SPY gained 2%, underperforming the market despite eight consecutive...</p
Higher oil prices and weaker discretionary spending weighed on Monro’s Q1 2027 results, though strategic pricing and tech tools mitigated losses. Monro Inc. reported flat tire unit volumes in Q1 2027 despite a 1.7% decline in comparable store sales, as geopolitical tension
The aircraft lessor increased full-year earnings guidance after reporting robust lease extensions and $1.4 billion in asset sales. AerCap Holdings raised its full-year 2026 adjusted EPS guidance to $16.80, up from prior expectations, driven by an 85% lease extension rate f
The medical technology firm reaffirmed full-year organic revenue growth guidance after exceeding Q2 earnings expectations. Integra LifeSciences Holdings Corporation reported Q2 2026 earnings above the high end of its guidance range, driven by improved operational execution
General Dynamics forecasts $55.7B revenue General Dynamics reported earnings of $4.24 per diluted share on revenue of $14.1 billion. The company's operating earnings were $1.460 billion and net earnings were $1.160 billion in Q2 2026. General Dynamics' backl
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.